###begin article-title 0
###xml 101 104 97 100 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 108 109 101 102 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 80 86 <span type="species:ncbi:10090">Murine</span>
The Catalytic Subunit of Protein Phosphatase 1 Gamma Regulates Thrombin-Induced Murine Platelet alphaIIbbeta3 Function
###end article-title 0
###begin p 1
###xml 44 47 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
###xml 142 145 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
###xml 176 179 <span type="species:ncbi:37162?0.34174508126603936">MAC</span>
Conceived and designed the experiments: FCG MAC RER KVV. Performed the experiments: FCG HH SP KWL NA KVV. Analyzed the data: FCG HH SP KWL NA MAC RER KVV. Wrote the paper: FCG MAC RER KVV. Maintained the aninal colony and genererated the experimental animals: NA.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 96 99 92 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 103 104 96 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 298 301 287 290 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 305 306 291 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Hemostasis and thrombosis are regulated by agonist-induced activation of platelet integrin alphaIIbbeta3. Integrin activation, in turn is mediated by cellular signaling via protein kinases and protein phosphatases. Although the catalytic subunit of protein phosphatase 1 (PP1c) interacts with alphaIIbbeta3, the role of PP1c in platelet reactivity is unclear.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 53 56 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 361 364 349 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 397 400 381 384 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 404 405 385 386 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 451 454 428 431 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 458 459 432 433 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 561 564 531 534 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 568 569 535 536 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 669 672 632 635 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 803 806 762 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 954 957 906 909 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1132 1135 1077 1080 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 807 811 <span type="species:ncbi:10090">mice</span>
Using gamma isoform of PP1c deficient mice (PP1cgamma-/-), we show that the platelets have moderately decreased soluble fibrinogen binding and aggregation to low concentrations of thrombin or protease-activated receptor 4 (PAR4)-activating peptide but not to adenosine diphosphate (ADP), collagen or collagen-related peptide (CRP). Thrombin-stimulated PP1cgamma-/- platelets showed decreased alphaIIbbeta3 activation despite comparable levels of alphaIIbbeta3, PAR3, PAR4 expression and normal granule secretion. Functions regulated by outside-in integrin alphaIIbbeta3 signaling like adhesion to immobilized fibrinogen and clot retraction were not altered in PP1cgamma-/- platelets. Thrombus formation induced by a light/dye injury in the cremaster muscle venules was significantly delayed in PP1cgamma-/- mice. Phosphorylation of glycogen synthase kinase (GSK3)beta-serine 9 that promotes platelet function, was reduced in thrombin-stimulated PP1cgamma-/- platelets by an AKT independent mechanism. Inhibition of GSK3beta partially abolished the difference in fibrinogen binding between thrombin-stimulated wild type and PP1cgamma-/- platelets.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
These studies illustrate a role for PP1cgamma in maintaining GSK3beta-serine9 phosphorylation downstream of thrombin signaling and promoting thrombus formation via fibrinogen binding and platelet aggregation.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 452 455 448 451 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 459 460 452 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 472 475 465 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Shattil1">[1]</xref>
###xml 556 559 549 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Li1">[2]</xref>
###xml 584 587 577 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Li2">[3]</xref>
###xml 589 592 582 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Li3">[4]</xref>
###xml 615 618 608 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Woulfe1">[5]</xref>
###xml 620 623 613 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Chen1">[6]</xref>
###xml 660 663 645 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Konopatskaya1">[7]</xref>
###xml 675 678 656 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Nagy1">[8]</xref>
###xml 725 728 700 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Li4">[9]</xref>
###xml 753 756 724 727 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 760 761 728 729 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 324 329 <span type="species:ncbi:9606">human</span>
###xml 333 338 <span type="species:ncbi:10090">mouse</span>
Agonist-induced platelet activation is critical for maintaining hemostasis at the site of vascular injury. Activation of platelets also contributes to the process of thrombosis following the rupture of atherosclerotic plaques. Thrombin generated at the site of injury binds to protease activated receptors (PAR)1 or PAR4 on human or mouse platelets, triggers protein phosphorylation on serine/threonine (Ser/Thr) residues and facilitates integrin alphaIIbbeta3 activation [1]. In particular, Ser/Thr kinases such as mitogen-activated protein kinase (MAPK) [2], protein kinase G (PKG) [3], [4], protein kinase B/AKT [5], [6], protein kinase C alpha (PKC alpha) [7], PKC theta [8] and glycogen synthase kinase 3beta (GSK3beta) [9] play a key role in alphaIIbbeta3 activation by thrombin or PAR4 activating peptide (PAR4-AP). Importantly, thrombin-induced and Ser/Thr kinase-mediated activation of signaling circuitry in platelets is reversible. Since protein phosphatases can fine-tune kinase-mediated signaling processes, we hypothesized that Ser/Thr phosphatases participate in hemostasis/thrombosis by regulating agonist-induced platelet activation.
###end p 9
###begin p 10
###xml 182 185 178 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 189 190 182 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 190 194 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Vijayan1">[10]</xref>
###xml 196 200 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Gushiken1">[11]</xref>
###xml 333 337 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Nishikawa1">[12]</xref>
###xml 338 342 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Higashihara1">[14]</xref>
###xml 393 397 386 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Lerea1">[15]</xref>
###xml 507 511 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-McCluskey1">[16]</xref>
###xml 652 655 641 644 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 659 660 645 646 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Platelets express several Ser/Thr phosphatases, and a pool of the catalytic subunits of protein phosphatase 1 (PP1c) and protein phosphatase 2A (PP2Ac) associates with integrin alphaIIbbeta3[10], [11]. Generic Ser/Thr phosphatase inhibitors like okadaic acid and calyculin A inhibited agonist-induced platelet aggregation, secretion [12]-[14], adhesion and spreading to immobilized fibrinogen [15]. Since these pharmacological agents inhibit several closely related phosphatases (namely, PP1, PP2A and PP4) [16], it is difficult to interpret the specific contribution of protein phosphatase 1 (PP1) and/or its isoforms in agonist-induced integrin alphaIIbbeta3 signaling. Our goal was to address a role for PP1 in platelets using a genetic approach.
###end p 10
###begin p 11
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Cohen1">[17]</xref>
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Ceulemans1">[18]</xref>
###xml 889 893 858 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Cohen1">[17]</xref>
PP1 is a major eukaryotic Ser/Thr protein phosphatase that regulates a variety of functions like glycogen metabolism, muscle contraction, transcription, translation and cell division [17], [18]. PP1 is a multimeric enzyme formed by the assembly of catalytic and regulatory subunits. PP1c is a 35-38 kDa protein that exists as three isoforms: alpha, beta/delta and gamma sharing greater than 90% amino acid sequence similarity. Two splice variants of PP1cgamma (PP1cgamma1 and PP1cgamma2) have also been identified. All PP1c isoforms are ubiquitously expressed, except for PP1cgamma2 that is testis specific. Cellular PP1 activity is regulated by multiple factors: 1) reversible phosphorylation of the regulatory subunits 2) dissociation of the regulatory and the catalytic subunits 3) allosteric regulation of the regulatory subunits and 4) inducible expression of the regulatory subunits [17].
###end p 11
###begin p 12
###xml 96 102 92 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ppp1cc</italic>
###xml 102 105 98 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 151 155 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Varmuza1">[19]</xref>
###xml 172 175 164 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 251 254 239 242 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 258 259 243 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 458 461 436 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Among the various isoforms of PP1c, mice bearing a targeted deletion of the gene for PP1cgamma [Ppp1cc-/-] are viable and are considered in this study [19]. Using PP1cgamma-/- platelets, we report a moderate decrease in low dose thrombin-induced alphaIIbbeta3 activation, soluble fibrinogen binding, platelet aggregation and thrombus formation. GSK3beta-Ser9 phosphorylation that promotes platelet function was also decreased in thrombin-stimulated PP1cgamma-/- platelets. GSK3beta inhibitor partially abrogated the difference in fibrinogen binding between thrombin-stimulated wild type and PP1cgamma-/- platelets. These studies suggest a positive role for PP1cgamma in thrombin-induced platelet functional responses.
###end p 12
###begin title 13
Materials and Methods
###end title 13
###begin title 14
Materials
###end title 14
###begin p 15
###xml 148 151 144 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 279 282 271 274 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 286 287 275 276 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 131 136 <span type="species:ncbi:10090">mouse</span>
###xml 267 273 <span type="species:ncbi:10090">murine</span>
###xml 921 926 <span type="species:ncbi:9606">human</span>
Unless stated, all reagents were from Sigma-Aldrich (St. Louis, MO). Fluorescein isothiocyanate (FITC)-conjugated antibodies (anti-mouse CD41 (alphaIIb) and CD62 (P-selectin) were from BD Bioscience (San Jose, CA). Phycoerythin-conjugated JON/A (recognizes activated murine alphaIIbbeta3) and thrombin were gifts from Dr. B. Nieswandt (University of Wurzburg, Germany) and Dr. J. Fenton (New York State Department of Health, Albany), respectively. ADP and collagen were from Helena Laboratories (Beaumont, TX). GSK3beta inhibitor VIII was from Calbiochem EMD4Biosciences (Darmstadt, Germany). Protease-activated receptor 4-activating peptide (PAR4AP) AYPGKF was synthesized by the Protein Core Facility at Baylor College of Medicine. Collagen-related peptide (CRP) was synthesized at Baylor College of Medicine and cross-linked by glutaraldehyde. Alexa 488-conjugated fibrinogen was from Invitrogen, (Carlsbad, CA) while human fibrinogen was from Enzyme Research Laboratories Inc. (South Bend, IN). Antibodies to phospho-AKT Ser473, phospho-GSK3beta Ser9 and AKT were obtained from Cell signaling (Boston, MA). Antibodies to thealpha, and gamma isoforms of PP1c, PAR3 and PAR4 were purchased from Santacruz Biotechnology (Santacruz, CA). beta isoform of PP1c was from Upstate Biotechnology/Millipore (Billerica, MA).
###end p 15
###begin title 16
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice Platelet Preparation
###end title 16
###begin p 17
###xml 166 170 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Varmuza1">[19]</xref>
###xml 362 365 354 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 704 705 696 697 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 707 708 699 700 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 730 731 722 723 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 734 735 726 727 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1234 1235 1226 1227 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 120 124 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 495 499 <span type="species:ncbi:10090">mice</span>
All animal studies were approved by the Institutional Animal Care and Use Committee at Baylor College of Medicine. CD-1 mice carrying the PP1cgamma targeted deletion [19] and subsequently backcrossed for 10 generations onto Balb/C background were obtained from Dr. S. Varmuza (University of Toronto). For most studies, 8-14 weeks old wild type (WT) and PP1cgamma-/- littermate mice matched for age and gender were used. Blood was collected from the inferior vena cava of isoflurane-anesthetized mice into acid-citric acid-dextrose (ACD) at a ratio of 1:10 (vol/vol). Whole blood was further diluted with an equal volume of Dulbecco's phosphate buffered saline (D-PBS) (Invitrogen), [2.6 mM KCl, 1.4 mM KH2PO4, 137 mM NaCl, 8 mM Na2HPO4] containing ACD (1:9 parts ACD/D-PBS). Platelet rich plasma (PRP) was obtained by centrifugation of the diluted blood at 68 g for 10 minutes at room temperature. PRP was further centrifuged at 754 g for10 minutes and the resulting platelet pellet was washed once in D-PBS and resuspended in D-PBS containing 0.005 U/ml apyrase to avoid desensitization of ADP receptors. Platelets were counted using a Coulter counter (Beckman-Coulter (Z1), Miami, FL) and adjusted to a final concentration of 2.5x108/ml and then allowed to rest for at least 1 hour.
###end p 17
###begin title 18
Immunoblotting Studies
###end title 18
###begin p 19
Resting platelets were lysed with 1% Triton X-100 containing lysis buffer supplemented with a cocktail of protease and phosphatase inhibitors. Forty microg of protein lysate were resolved on 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotted with antibodies to different isoforms of PP1c, PAR3, PAR4 and actin. In some experiments, washed platelet treated with varying concentrations of thrombin for 2 minutes were lysed and immunoblotted with antibodies to phospho-AKT Ser 473, phospho-GSK3beta Ser9, and AKT. Binding of primary antibodies were detected by HRP-conjugated secondary antibodies developed using ECL-system (Amersham Biosciences).
###end p 19
###begin title 20
Fibrinogen Binding, Flow Cytometry Analysis and Platelet Aggregation
###end title 20
###begin p 21
###xml 87 88 87 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 135 136 135 136 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 153 154 153 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 966 969 931 934 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 973 974 935 936 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1026 1029 980 983 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 1033 1034 984 985 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 832 837 <span type="species:ncbi:10090">mouse</span>
###xml 863 868 <span type="species:ncbi:10090">mouse</span>
###xml 923 928 <span type="species:ncbi:10090">mouse</span>
To study fibrinogen binding, washed platelets were diluted to a concentration of 2.5x107/ml with Tyrode's buffer containing 1.8 mM CaCl2 and 0.49 mM MgCl2. Platelets were stimulated with various concentrations of the following agonists: thrombin (0.005, 0.01, 0.02, 0.1 U/ml), adenosine diphosphate (ADP) (5, 10, 20 microM), collagen (1, 2.5 and 5 microg/ml), collagen-related peptide (CRP) (0.1, 0.2 microg/ml), PAR4-AP (100, 500 microM) followed by addition of Alexa 488-conjugated fibrinogen (50 microg/ml final concentration) at room temperature for 15-20 minutes. In some studies, platelets were pretreated with control (DMSO) or 10 microM GSK3beta inhibitor VIII for 30 minutes before stimulation with thrombin (0.02 U/ml). In other studies, platelets (resting or thrombin-stimulated) were incubated with FITC-conjugated anti-mouse CD41, PE-conjugated anti-mouse GPIbalpha, PE-labeled JON/A, and FITC-conjugated anti-mouse P-selectin antibodies to detect alphaIIbbeta3, GPIbalpha expression, activation of integrin alphaIIbbeta3, and alpha granule secretion, respectively. Fluorescence-activated cell sorting (FACS) analysis of platelets was performed using an EPICS-XL flow cytometry (Beckman Coulter). Platelet aggregation in response to various agonists was initiated by addition of various agonists to a 225 microl aliquot of washed platelets in a four channel Bio/Data PAP-4C aggregometer (Biodata Corporation, Horsham, PA)
###end p 21
###begin title 22
Platelet Adhesion and Clot Retraction
###end title 22
###begin p 23
###xml 220 221 216 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 277 278 273 274 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 295 296 291 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 550 556 540 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">versus</italic>
###xml 705 706 691 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 748 749 734 735 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 96 102 <span type="species:ncbi:9913">Bovine</span>
###xml 660 665 <span type="species:ncbi:10090">mouse</span>
Ninety six well plates were coated with 100 microg/ml of fibrinogen and blocked with 5 mg/ml of Bovine Serum Albumin (BSA). Control wells were coated with only BSA. Fibrinogen or BSA coated wells were incubated with 1x107 washed platelets in D-PBS supplemented with 1.8 mM CaCl2 and 0.49 mM MgCl2 for varying time periods at 37degreesC. Unbound platelets were washed and the attached platelets were quantified by assaying for acid phosphatase activity at 405 nM. The number of platelets attached was obtained by using a standard curve for absorbance versus cell number. Fibrin-clot retraction, was initiated by the addition of 1 U/ml thrombin to 150 microl of mouse platelet-rich plasma containing (2.5x108 platelets/ml) supplemented with 3 mM CaCl2. After incubating at RT for varying time periods, the amount of liquid not incorporated into the clot is measured. The volume of the clot was determined by subtracting the measured volume from 150 microl (initial volume). Clot volume was expressed as a percentage of the initial volume.
###end p 23
###begin title 24
In Vivo Platelet Thrombus Formation
###end title 24
###begin p 25
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Rumbaut1">[20]</xref>
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Patel1">[21]</xref>
###xml 1336 1337 1320 1321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
Microvascular thrombosis was examined in the cremaster venules using a previously well described model of light/dye -induced endothelial injury by intravital microscopy [20], [21]. Briefly, male mice anesthetized with 50 mg/kg phenobarbital sodium were placed on a custom plexiglas tray maintained at 37degreesC with a homeothermic blanket. To assist in breathing, a tracheotomy was performed. Later, an internal jugular vein and common carotid artery were cannulated to facilitate administration of various preparations and monitoring of blood pressure/heart rate, respectively. The cremaster microvascular bed was prepared, perfused with bicarbonate-buffered saline solution (pH range, 7.35-7.45) at 35degreesC and transferred to the stage of an upright intravital video microscope (BX-50; Olympus, Tokyo, Japan). After equilibration for 30 minutes, 10 mL/kg 5% FITC-labeled dextran (150 kD) was injected intravenously through the jugular vein. A suitable venule was selected after survey of the vascular bed with a 4x objective (NA 0.13) lens. Following the measurement of the diameter and blood flow velocity of the vessel (Doppler velocimeter; Microcirculation Research Institute, College Station, TX), a photochemical injury was initiated by exposing approximately 100 microm of the vessel to filtered excitation light at 0.6 W/cm2 (from a 175W xenon lamp; Sutter Instrument, Novato, CA; and an HQ-FITC filter cube; Chroma Technology, Brattleboro, VT). Epi-illumination was applied continuously, and the time of onset of platelet aggregates (thrombus onset) and the time of flow cessation (for at least 60 seconds) were monitored and recorded using a 40x water-immersion objective (NA 0.8) by an observer who was blinded to the genotype of the animals. Thrombi were induced in 1-2 venules per animal, and the results for each animal were averaged.
###end p 25
###begin title 26
Tail-Bleeding Times
###end title 26
###begin p 27
###xml 44 47 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
Tails of anesthetized mice (WT and PP1cgamma-/-) were severed with a scalpel 1 mm from the tip and immediately immersed in a tube containing PBS solution at 37degreesC. Thirty seconds later, the tail was immersed into a new tube with PBS and this process of transferring the tail to a new tube was repeated until the bleeding stopped. The time from the incision to cessation of blood (as revealed by visual examination of blood in the tubes) were recorded as tail bleeding times.
###end p 27
###begin title 28
Statistical Analysis
###end title 28
###begin p 29
###xml 104 105 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Results are expressed as means +/- SEM. Experimental conditions were compared by using paired student's t test.
###end p 29
###begin title 30
Results
###end title 30
###begin title 31
###xml 10 13 6 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
PP1cgamma -/- Platelets Exhibited Comparable Expression of Other PP1c Isoforms
###end title 31
###begin p 32
###xml 134 137 122 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 149 158 137 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g001">Figure 1C</xref>
###xml 295 298 272 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 305 321 282 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g001">Figure 1A and 1B</xref>
###xml 407 437 384 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g001">Figure 1 A, Band C lower panel</xref>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
Immunoblotting studies with an antibody specific for the gamma isoform of PP1c confirmed the absence of PP1cgamma protein in PP1cgamma-/- platelets (Figure 1C). Furthermore, there was no evidence for a compensatory up-regulation of alpha and beta isoforms of PP1c in the platelets from PP1cgamma-/- mice (Figure 1A and 1B). These blots were stripped and reprobed with actin to ensure equal protein loading (Figure 1 A, Band C lower panel).
###end p 32
###begin title 33
PP1c isoforms in platelets.
###end title 33
###begin p 34
###xml 1 4 1 4 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A&#8211;C</bold>
###xml 54 57 50 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
(A-C) Platelet lysate from wild type (WT) or PP1cgamma-/- mice were evaluated by SDS-PAGE and Western blotting using isoform specific antibodies to alpha, beta and gamma (recognizes gamma1 and gamma2 splice variants). These membranes were stripped and reprobed with actin to demonstrate equal protein loading (lower panels). Blots are representative of three independent experiments.
###end p 34
###begin title 35
###xml 10 13 6 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
PP1cgamma -/- Platelets Exhibited a Mild Agonist-Specific Impairment in Fibrinogen Binding and Aggregation
###end title 35
###begin p 36
###xml 28 34 28 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ppp1cc</italic>
###xml 111 114 107 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 470 473 462 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 485 494 477 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g002">Figure 2A</xref>
###xml 556 559 544 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 818 821 778 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 833 842 793 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g002">Figure 2B</xref>
###xml 915 918 871 874 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1047 1050 999 1002 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 1054 1055 1003 1004 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1113 1116 1058 1061 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1292 1296 1237 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Lau1">[22]</xref>
###xml 1297 1301 1242 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Satoh1">[24]</xref>
###xml 1576 1579 1513 1516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1685 1694 1622 1631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g002">Figure 2C</xref>
###xml 115 119 <span type="species:ncbi:10090">mice</span>
###xml 1216 1221 <span type="species:ncbi:9606">human</span>
###xml 1381 1386 <span type="species:ncbi:10090">mouse</span>
To determine if the loss of Ppp1cc gene affected platelet reactivity washed platelets from the WT and PP1cgamma-/- mice were stimulated with platelet agonists and analyzed for soluble fibrinogen binding. Low concentrations of strong agonists like thrombin, collagen and dilute suspension of platelets were used to ensure that platelets did not aggregate in this assay. ADP, collagen and CRP induced-soluble fibrinogen binding were comparable between the WT and PP1cgamma-/- platelets (Figure 2A). In contrast, addition of low doses of thrombin to PP1cgamma-/- platelets resulted in a modest but significant decrease in the soluble fibrinogen binding. A approximately42% (p = 0.02) and approximately45% (p = 0.01) decreased fibrinogen binding in response to 0.01 U/ml and 0.02 U/ml of thrombin was observed in PP1cgamma-/- platelets (Figure 2B). However, the difference in fibrinogen binding between WT and PP1cgamma-/- platelets was lost with increasing concentrations of thrombin (not shown). Addition of cation chelator EDTA known to block alphaIIbbeta3 function inhibited fibrinogen binding in WT and PP1cgamma-/- platelets to values obtained in unstimulated platelets. Many, but not all responses of thrombin in human platelets could be reproduced by thrombin receptor activating peptide [22]-[24]. To explore whether PP1cgamma participated in thrombin signaling downstream of mouse thrombin receptor PAR4, we stimulated platelets with protease-activated receptor 4 activating peptide (PAR-4AP) and assessed fibrinogen binding. Compared with wild type platelets, PP1cgamma-/- platelets showed only marginally decreased soluble fibrinogen binding in response to PAR-4AP (P = 0.05) (Figure 2C).
###end p 36
###begin title 37
###xml 87 90 83 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Thrombin specific impairment in soluble fibrinogen binding and aggregation in PP1cgamma-/- platelets.
###end title 37
###begin p 38
###xml 37 40 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 89 90 85 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 103 104 99 100 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 118 119 114 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 427 430 417 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 767 770 749 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 967 970 943 946 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Washed platelets from WT or PP1cgamma-/- mice were stimulated with ADP, collagen or CRP (A), thrombin (B) or PAR4-AP (C) in the presence of Alexa 488 fibrinogen and bound fibrinogen analyzed by flow cytometry as mean fluorescence intensity (MFI). Data are +/-SEM of 9-11 experiments for ADP, thrombin and collagen and 13-14 experiments for PAR4-AP. As compared to the WT platelets, the decreased fibrinogen binding in PP1cgamma-/- platelets were significant at *p = 0.02 (for 0.01 U/ml thrombin); #p = 0.01 (for 0.02 U/ml thrombin); *p = 0.05 (for 200 microM PAR4-AP). In other experiments (n = 3), platelets were pretreated with 0.5 mM EDTA or 2 mM apyrase (ADP scavenger) prior to stimulation with 0.02 U/ml thrombin. (D) Percentage aggregation for WT and PP1cgamma-/- platelets in response to the indicated doses of thrombin, ADP and collagen. Studies are indicated as +/-SEM of 5-6 experiments. The decreased aggregation in 0.02 U/ml thrombin stimulated PP1cgamma-/- platelets compared to WT platelets was significant at *p = 0.04.
###end p 38
###begin p 39
###xml 183 186 179 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 235 238 227 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 411 414 387 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 426 435 402 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g002">Figure 2D</xref>
###xml 539 542 511 514 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Soluble fibrinogen binding under stirring conditions can lead to platelet aggregation. Next, we determined whether platelet aggregation in response to agonist was altered in PP1cgamma-/- platelets. Compared with WT platelets, PP1cgamma-/- platelets demonstrated approximately60% decreased aggregation to 0.02 U/ml thrombin. Aggregation in response to ADP and collagen was comparable between the WT and PP1cgamma-/- platelets (Figure 2D). Since moderate differences in soluble fibrinogen binding and aggregation between the WT and PP1cgamma-/- platelets were noticed only at low thrombin concentrations and not with other agonists, we conducted the rest of the studies in this report with only low dose thrombin.
###end p 39
###begin title 40
###xml 10 13 6 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 80 83 72 75 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 87 88 76 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 123 126 108 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 130 131 112 113 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
PP1cgamma -/- Platelets Exhibited Decreased Thrombin-Induced Activation of alphaIIbbeta3 despite Normal Expression of alphaIIbbeta3, Thrombin Receptors and Normal Granule Secretion
###end title 40
###begin p 41
###xml 94 97 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 453 456 445 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 468 477 460 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g003">Figure 3A</xref>
###xml 550 554 538 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-De1">[25]</xref>
###xml 624 627 604 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 711 714 687 690 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 718 719 691 692 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 759 762 728 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 811 814 776 779 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 818 819 780 781 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 952 955 910 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1026 1029 980 983 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1106 1115 1060 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g003">Figure 3B</xref>
###xml 1144 1147 1094 1097 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 1151 1152 1098 1099 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1241 1244 1184 1187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1251 1260 1194 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g003">Figure 3C</xref>
###xml 1343 1346 1282 1285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1477 1480 1412 1415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1523 1526 1454 1457 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 1530 1531 1458 1459 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1666 1669 1586 1589 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1681 1690 1601 1610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g003">Figure 3D</xref>
###xml 1813 1816 1729 1732 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1953 1956 1865 1868 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1968 1977 1880 1889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g002">Figure 2B</xref>
###xml 2074 2077 1982 1985 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2175 2178 2079 2082 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 2182 2183 2083 2084 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 2338 2341 2235 2238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 799 805 <span type="species:ncbi:10090">murine</span>
###xml 1245 1249 <span type="species:ncbi:10090">mice</span>
###xml 1481 1485 <span type="species:ncbi:10090">mice</span>
To identify potential mechanisms for the decreased reactivity in thrombin stimulated PP1cgamma-/- platelets, we analyzed the expression of thrombin receptors PAR3 and PAR4. Because reliable antibodies that detect PAR4 by immunofluoresence were not readily available, we subjected platelet lysate to immunoblotting experiments with anti-PAR3 and PAR4 antibodies. Comparable expression of PAR3 and PAR4 receptors was observed between the WT and PP1cgamma -/- platelets (Figure 3A). Besides PARs, GPIbalpha serves as high affinity thrombin binding site [25]. However, GPIbalpha expression was not different in WT and PP1cgamma -/-platelets (data not shown). Next, we studied the activation status of integrin alphaIIbbeta3 in thrombin-stimulated WT and PP1cgamma-/- platelets by flow cytometry using a murine alphaIIbbeta3 activation-specific JON/A antibody. Under resting conditions, there was no difference in JON/A binding between the WT and PP1cgamma -/- platelets. In contrast, addition of thrombin (0.02 U/ml) to PP1cgamma -/- platelets resulted in a moderate but significant decrease in JON/A binding (Figure 3B). Expression levels of alphaIIbbeta3 in the resting and thrombin stimulated platelets were comparable in the WT and PP1cgamma-/- mice (Figure 3C). This indicates that the decreased JON/A binding in thrombin stimulated PP1cgamma-/- platelets were not due to the altered integrin expression. Potential alterations in platelet granule secretion events in PP1cgamma-/- mice could account for the decreased alphaIIbbeta3 activation at low doses of thrombin. However, secretion of P-selectin (alpha granule content) was not altered between WT and PP1cgamma-/- platelets (Figure 3D). Furthermore, addition of exogenous fibrinogen did not rescue the decreased aggregation of thrombin stimulated PP1cgamma -/- platelets (not shown). ADP scavenger apyrase did not abolish thrombin-induced fibrinogen binding difference between the WT and PP1cgamma-/- platelets (Figure 2B). This observation suggests that the fibrinogen binding difference between the WT and PP1cgamma -/- platelets is not dependent on dense granule ADP. Thus, these studies suggest that decreased alphaIIbbeta3 activation and not altered receptor expression or granule secretion may have contributed to the decreased fibrinogen binding in thrombin-treated PP1cgamma-/- platelets.
###end p 41
###begin title 42
###xml 39 42 35 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 46 47 39 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 75 78 64 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Expression of thrombin receptors, alphaIIbbeta3 and P-selectin in PP1cgamma-/- platelets.
###end title 42
###begin p 43
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 358 359 334 335 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 374 377 346 349 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 393 394 365 366 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 425 426 397 398 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 611 614 577 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
(A) Lysate from resting washed platelets was evaluated by SDS-PAGE and immunoblotted with anti-PAR3 antibody (approximately43 kDa). The blot was stripped and reprobed with anti- PAR4 (approximately38 kDa) and then with anti-actin (loading) antibodies. Blots are representative of two experiments. Washed platelets were incubated with anti-JON/A PE antibody (B) or anti-alphaIIb FITC antibody (C) or anti-P-selectin antibody (D) and subjected to flow cytometry. Results are expressed as +/-SEM of 5-6 experiments. Compared to thrombin stimulated WT platelets, the decreased binding of JON/A antibody to PP1cgamma-/- platelets was significant at *p = 0.003.
###end p 43
###begin title 44
###xml 9 12 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 64 67 56 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 71 72 60 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
PP1cgamma-/- Platelet Exhibited Normal Outside in Integrin alphaIIbbeta3 Signaling
###end title 44
###begin p 45
###xml 62 65 58 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 69 70 62 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 110 113 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 190 193 175 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 266 275 251 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g004">Figure 4A</xref>
###xml 392 395 373 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 402 411 383 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g004">Figure 4B</xref>
###xml 478 481 455 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 485 486 459 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
We assessed if functions mediated by outside-in integrin alphaIIbbeta3 signaling were altered in the PP1cgamma-/- mice. In contrast to the data from soluble fibrinogen, adhesion of PP1cgamma-/- platelets to immobilized fibrinogen was comparable to the WT platelets (Figure 4A). Thrombin-induced clot retraction of platelet rich plasma samples was also not altered between the WT and PP1cgamma-/- mice (Figure 4B). Collectively, these studies imply that outside-in integrin alphaIIbbeta3 signaling processes were not altered by the lack of PP1cgamma in platelets.
###end p 45
###begin title 46
###xml 25 28 21 24 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 32 33 25 26 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 66 69 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Outside-in integrin alphaIIbbeta3 signaling functions in PP1cgamma-/- platelets.
###end title 46
###begin p 47
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 201 202 199 200 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
(A). Washed platelets were incubated with immobilized fibrinogen-coated micro titer wells for the indicated periods of time and adhesion quantified. The data are expressed as +/-SEM of 3 experiments. (B) Fibrin clot retraction was examined following the addition of thrombin to platelet-rich plasma. Volume of the clot is expressed as +/-SEM of 3 experiments.
###end p 47
###begin title 48
###xml 9 12 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 13 17 <span type="species:ncbi:10090">Mice</span>
PP1cgamma-/- Mice Exhibited Delayed Thrombus Formation in a Light-Dye Injury Thrombosis Model
###end title 48
###begin p 49
###xml 40 43 36 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 63 71 59 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 104 111 100 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 157 160 149 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 263 267 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Rumbaut1">[20]</xref>
###xml 358 361 346 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 368 375 356 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g005">Fig. 5A</xref>
###xml 524 527 508 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 534 541 518 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g005">Fig. 5A</xref>
###xml 630 633 610 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 696 698 662 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 715 717 679 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 835 838 795 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 897 899 851 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 916 918 868 870 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 994 997 942 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1232 1235 1172 1175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1242 1251 1182 1191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g005">Figure 5B</xref>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 528 532 <span type="species:ncbi:10090">mice</span>
###xml 634 638 <span type="species:ncbi:10090">mice</span>
###xml 839 843 <span type="species:ncbi:10090">mice</span>
###xml 998 1002 <span type="species:ncbi:10090">mice</span>
###xml 1236 1240 <span type="species:ncbi:10090">mice</span>
To establish if the defect in PP1cgamma -/- platelets observed in vitro might affect thrombus formation in vivo, we studied the responses of WT and PP1cgamma-/- mice to a light/dye-induced injury model that has been previously shown not to denude the endothelium [20]. The initiation time for thrombus formation was not different between the WT and PP1cgamma-/- mice (Fig. 5A). In contrast, we noticed a moderate but significant (P = 0.03) delay in the time for complete cessation of blood flow (occlusion time) in PP1cgamma-/- mice (Fig. 5A). Microvascular diameter and wall shear rate was comparable between the WT and PP1cgamma-/- mice (23.3+/-0.3 microm vs. 24.6+/-0.5 microm and 515+/-28 sec-1 vs. 516+/-29 sec-1, respectively). Similarly, blood pressure and heart rate was not significantly different between the WT and PP1cgamma-/- mice (82.8+/-1.9 mmHg vs. 81.5+/-21. mmHg and 436+/-14 min-1 and 465+/-12 min-1, respectively) suggesting that the delayed thrombus formation in PP1cgamma -/- mice was independent of these above mentioned factors. Thus, in this thrombosis model, PP1cgamma participates modestly in stabilizing thrombus formation. In contrast, tail bleeding times were not different between the WT and PP1cgamma-/- mice (Figure 5B).
###end p 49
###begin title 50
Role of PP1cgamma in thrombosis and hemostasis injury models.
###end title 50
###begin p 51
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 120 123 116 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 376 379 366 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 416 417 406 407 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 469 472 455 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
###xml 473 477 <span type="species:ncbi:10090">mice</span>
(A). Light/dye -induced microvascular thrombosis was studied in the venules of the cremaster muscles of WT and PP1cgamma-/- mice by intra vital microscopy. The onset of thrombosis (onset) and the cessation of blood flow following the injury were monitored. Results are expressed as +/-SEM of 13 experiments. Compared to the WT, the delayed time for flow cessation in PP1cgamma-/- mice was significant at *p = 0.03. (B). Tail vein bleeding times from 13 WT and PP1cgamma-/- mice are shown.
###end p 51
###begin title 52
###xml 29 32 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Thrombin-Stimulated PP1cgamma-/- Platelets Exhibited Decreased Glycogen Synthase Kinase3 beta -Serine 9 Phosphorylation in an AKT Independent Manner
###end title 52
###begin p 53
###xml 209 212 202 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 239 242 232 235 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 248 251 241 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 264 267 254 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 383 386 373 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 456 459 446 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Chen1">[6]</xref>
###xml 673 676 655 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 688 704 670 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g006">Figure 6A and 6B</xref>
###xml 871 875 847 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Zhang1">[26]</xref>
###xml 1030 1033 1000 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Li4">[9]</xref>
###xml 1070 1073 1040 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Li4">[9]</xref>
###xml 1213 1216 1176 1179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1739 1742 1674 1677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Li4">[9]</xref>
###xml 213 217 <span type="species:ncbi:10090">mice</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
Platelet functional responses to thrombin are mediated in part by activation of signaling molecules in the PI3K-AKT-GSK-3beta circuitry. Interestingly, there exist some similarly in the phenotype of PP1cgamma -/- mice when compared to AKT2-/-, AKT1-/- and GSK3beta+/- mice. All four null mice predominantly showed thrombin or PAR4 specific impairment in platelet function except AKT1-/- mice, which also exhibited defects in platelet responses to collagen [6]. Therefore, we investigated if PP1cgamma regulates thrombin-induced signaling to AKT. Activation of AKT as measured by phosphorylation of AKT-Ser473 was comparable between the thrombin stimulated WT and PP1cgamma -/- platelets (Figure 6A and 6B). Next, we assessed the activation of GSK3beta (AKT substrate) because PP1 can regulate GSK-3beta Ser9 phosphorylation, independent of AKT, under in vitro conditions [26]. GSK3beta is a suppressor of platelet function and agonist-induced Ser9 phosphorylation decreases GSK3beta kinase activity and promotes platelet function [9]. Consistent with the earlier report [9], thrombin stimulation in WT platelets resulted in sustained phosphorylation of GSK-3beta-Ser9. Unexpectedly, thrombin-stimulated PP1cgamma -/- platelets showed a maximum of approximately1.9 fold decreased GSK-3beta-Ser9 phosphorylation (6A and 6C). These observations imply a role for PP1cgamma in GSK-3beta-Ser9 phosphorylation downstream of thrombin signaling by an AKT independent pathway. It should be emphasized that although a majority of PAR4-stimulated GSK3beta-Ser9 phosphorylation was previously shown to be dependent on PI3K/AKT signaling, the same study also reported a fraction of GSK3beta-Ser9 phosphorylation that was independent of PI3K/AKT pathway [9]. Thus, a pathway involving PP1cgamma might represent one of the non-AKT dependent mechanisms that could potentially regulate GSK3beta-Ser9 phosphorylation.
###end p 53
###begin title 54
###xml 75 78 68 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Decreased phosphorylation of GSK3beta-Ser9 in thrombin stimulated PP1cgamma-/- platelets.
###end title 54
###begin p 55
###xml 1 2 1 2 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 200 207 197 204 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B and C</bold>
###xml 316 319 306 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 421 424 404 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 580 581 555 556 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 675 678 643 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 727 730 691 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
(A). Platelet lysate from resting (0) and thrombin activated (0.005, 0.01 and 0.02 U/ml) was separated on an SDS-PAGE and immunoblotted with antibodies to AKT-Ser473, GSK3beta- Ser9 and AKT (total). (B and C) Densitometric quantification of phosphorylation levels for AKT-Ser473 and GSK3beta-Ser9 in WT and PP1cgamma-/- stimulated platelets. The decreased phosphorylation of GSK3beta-Ser9 in thrombin-stimulated PP1cgamma-/- platelets was significant at diamondp = 0.05 (for 0.01 U/ml thrombin); *p = 0.02 (for 0.02 U/ml thrombin). Data are expressed as +/-SEM of 5 experiments. (D) Effect of GSK3beta inhibitor VIII on thrombin-induced fibrinogen binding on WT and PP1cgamma-/- platelets. Compared with WT platelets, PP1cgamma-/- platelets displayed approximately40% decreased fibrinogen binding in response to 0.02 U/ml thrombin in the presence of solvent control (DMSO) (*P = 0.048) and GSK3 inhibitor VIII (GSK3beta) partially reduced the difference to 23%. Data are expressed as +/-SEM of 3-4 experiments.
###end p 55
###begin p 56
###xml 255 258 239 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 308 311 288 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 517 520 478 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 719 722 664 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 897 900 835 838 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Since GSK3beta-Ser9 phosphorylation inhibits the constitutive GSK3beta activity, we examined whether the decreased GSK3beta-Ser9 phosphorylation (active GSK3beta) upon thrombin stimulation could contribute to the decreased fibrinogen binding in PP1cgamma -/- platelets. Compared with WT platelets, PP1cgamma -/- platelets exhibited approximately40% decreased fibrinogen binding upon stimulation with 0.02 U/ml thrombin in the presence of DMSO (control). However, in the presence of GSK3beta inhibitor VIII, PP1cgamma -/- platelets exhibited approximately23% decreased fibrinogen binding compared to the WT platelets, suggesting that the difference in fibrinogen binding between the thrombin-stimulated WT and PP1cgamma -/- platelets were partially abolished by GSK3beta inhibitor. Thus, these studies imply that GSK3 activity, in part, contributes to the decreased fibrinogen binding in PP1cgamma -/- platelets.
###end p 56
###begin title 57
Discussion
###end title 57
###begin p 58
###xml 210 213 195 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 297 300 278 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 399 402 376 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 586 589 551 554 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 593 594 555 556 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 660 667 622 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
Compared with Ser/Thr kinases, a specific role for PP1cgamma in platelet activation is unclear. Although a compensatory up-regulation of PP1calpha and PP1cbeta isoforms was not particularly evident in PP1cgamma-/- platelets, a potential redundancy between the individual PP1c isoforms in PP1cgamma-/- platelet function is to be expected and may underlie the mild platelet phenotype seen in PP1cgamma-/- mice. Despite this constrain, our studies uncovers two novel aspects of PP1cgamma with regards to the platelet biology. 1) PP1cgamma regulates low dose thrombin-induced integrin alphaIIbbeta3 activation, soluble fibrinogen binding, platelet aggregation and in vivo thrombus formation. 2) PP1cgamma is needed for a sustained thrombin-stimulated GSK3beta-Ser9 phosphorylation in platelets.
###end p 58
###begin p 59
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ppp1c</italic>
###xml 98 102 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Varmuza1">[19]</xref>
###xml 352 355 336 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 359 360 340 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 472 481 453 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g002">Figures 2</xref>
###xml 850 853 816 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 860 869 826 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g005">Figure 5A</xref>
###xml 887 890 849 852 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1007 1014 965 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1066 1073 1024 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1123 1131 1081 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1231 1234 1185 1188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1283 1292 1237 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g005">Figure 5B</xref>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 854 858 <span type="species:ncbi:10090">mice</span>
###xml 1235 1239 <span type="species:ncbi:10090">mice</span>
Targeted disruption of the Ppp1c gene in mice led to impaired spermiogenesis and male infertility [19]. Although PP1cgamma is more intensely studied in the area of reproductive biology, our studies indicate that PP1cgamma can also regulate platelet activation in an agonist-specific manner. In particular, a subtle role for PP1cgamma was noted in alphaIIbbeta3 activation, fibrinogen binding and aggregation response to low dose thrombin but not to ADP, collagen and CRP (Figures 2). Perhaps, activation of multiple redundant signaling pathways by higher concentrations of thrombin and/or other agonists might favor activation of PP1calpha or PP1cbeta in the absence of PP1cgamma to sustain activation of platelets. More importantly, thrombus formation induced by light-dye injury was significantly delayed in the cremasteric venules of the PP1cgamma-/- mice (Figure 5A). Since PP1cgamma-/- is not a platelet specific knockout, contribution of PP1cgamma from other cell types within the vasculature towards in vivo thrombosis cannot be ruled out. Nevertheless, this in vivo study is consistent and correlates well with the in vitro platelet data. In contrast to the thrombosis model, normal hemostasis was not altered in PP1cgamma -/- mice as revealed by normal tail bleeding times (Figure 5B). It is not known whether the differential role played by PP1cgamma in hemostasis versus thrombosis models was due to the intrinsic differences in the type and extent of injury in the two models, or due to the compensatory mechanisms, which was sufficient to drive hemostasis but not thrombosis.
###end p 59
###begin p 60
###xml 63 66 59 62 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 70 71 63 64 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 130 133 119 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 137 138 123 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 221 225 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Vijayan1">[10]</xref>
###xml 269 272 251 254 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 276 277 255 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 373 377 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Bynagari1">[27]</xref>
###xml 490 493 455 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 497 498 459 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 554 557 512 515 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 561 562 516 517 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 708 711 659 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 765 768 712 715 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 772 773 716 717 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 934 937 870 873 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 941 942 874 875 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1052 1056 974 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Watanabe1">[28]</xref>
###xml 1171 1174 1089 1092 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 1178 1179 1093 1094 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1282 1285 1193 1196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1588 1592 1499 1503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Nishikawa1">[12]</xref>
###xml 1593 1597 1504 1508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Lerea1">[15]</xref>
###xml 712 716 <span type="species:ncbi:10090">mice</span>
###xml 1286 1290 <span type="species:ncbi:10090">mice</span>
###xml 1341 1346 <span type="species:ncbi:9606">human</span>
Previous studies have identified that outside-in integrin alphaIIbbeta3 signaling mechanisms facilitated the dissociation of alphaIIbbeta3 bound PP1c, with the ability to dephosphorylate platelet myosin light chain (MLC) [10]. Following the engagement of integrin alphaIIbbeta3, PP1cgamma was shown to be involved in the dephosphorylation of ADP-induced nPKCeta activation [27]. These observations imply that PP1cgamma might regulate platelet functions mediated by outside-in integrin alphaIIbbeta3 signaling processes. However, outside-in integrin alphaIIbbeta3 signaling dependent functions like adhesion and spreading (not shown) to immobilized fibrinogen and clot retraction were not altered in PP1cgamma-/- mice. Since all PP1c isoforms can interact with alphaIIbbeta3 (unpublished observation), one possibility is that the PP1cgamma isoform does not participate in the functional responses initiated by outside-in integrin alphaIIbbeta3 signaling. Indeed, platelet MLC is dephosphorylated by PP1cbeta/delta (myosin phosphatase) but not PP1cgamma [28]. Another possibility relates to an easy compensation by other PP1c isoforms following engagement of integrin alphaIIbbeta3 to alter platelet outside-in signaling functions. Finally, the platelet functional data from PP1cgamma-/- mice was not completely consistent with the studies in human platelets treated with Ser/Thr protein phosphatase inhibitors. The latter studies employed calyculin A and okadaic acid and observed inhibition of platelet aggregation and secretion to various agonists and adhesion to immobilized fibrinogen [12]-[15]. These differences may stem from the fact that the platelet phenotype obtained in response to the pharmacological agents might be due to inhibition of multiple phosphatases as opposed to inhibition of only PP1cgamma in this study.
###end p 60
###begin p 61
###xml 66 69 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 129 132 121 124 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 136 137 125 126 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 256 259 241 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 286 287 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 290 291 273 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 329 330 310 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 333 334 314 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 355 358 330 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 688 691 651 654 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 695 696 655 656 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 996 999 945 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1011 1028 960 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g006">Figures 6A and 6C</xref>
###xml 1145 1149 1091 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Cross1">[29]</xref>
###xml 1289 1293 1232 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Barry1">[30]</xref>
###xml 1441 1444 1378 1381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Li4">[9]</xref>
###xml 1831 1834 1752 1755 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1940 1943 1854 1857 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 1947 1948 1858 1859 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 2155 2158 2059 2062 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2170 2179 2074 2083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008304-g006">Figure 6D</xref>
###xml 2315 2318 2215 2218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 1368 1372 <span type="species:ncbi:10090">mice</span>
Decreased platelet responses to thrombin observed in the PP1cgamma-/- mice was not due to altered expression of PAR3, PAR4, alphaIIbbeta3 or decreased platelet counts. In fact, we noticed a moderate but significant increase in platelet numbers in PP1cgamma-/- mice [Mean+/-SEM 596.78x103/mm3+/-17.94 in WT compared with 693.71x103/mm3+/-19.87 in PP1cgamma-/- mice; N = 12, P = 0.0003]. However, we cannot rule out the possibility that the lack of PP1cgamma isoform could alter PAR4 activation associated proximal signaling events such as binding of GTP to the G proteins that couple to PAR4. Perhaps, multiple substrates of PP1cgamma may exist in the signaling pathways that control alphaIIbbeta3 activation downstream of thrombin signaling. Absence of PP1cgamma may alter the phosphorylation of one or more of these cellular proteins, thereby suppressing the platelet function. In fact, we noticed that the GSK3beta-Ser9 phosphorylation was significantly reduced in thrombin stimulated PP1cgamma-/- platelets (Figures 6A and 6C). GSK3beta is Ser/Thr kinase and phosphorylation of Ser9 residue inhibits its constitutively active kinase activity [29]. Although an initial study using a more generic and non selective GSK3 inhibitor implied a positive role for GSK3beta in platelet function [30], a more recent comprehensive genetic analysis using GSK3beta heterozygote mice revealed that GSK3beta is a negative regulator of platelet function [9]. Results from the latter study indicated that thrombin stimulated GSK3beta Ser 9 phosphorylation and removed the suppressive role of GSK3beta on platelet function. Thus, a decreased GSK3beta-Ser9 phosphorylation upon thrombin stimulation is predicted to maintain a constitutive GSK3beta activity, thereby inhibiting the platelet function. Indeed, our studies revealed that the PP1cgamma-/- platelets stimulated with thrombin had decreased GSK3beta-Ser9 phosphorylation along with decreased alphaIIbbeta3 activation, fibrinogen binding, aggregation and delayed thrombus formation. Moreover, pharmacological inhibition of GSK3beta partially abolished the difference in fibrinogen binding between WT and PP1cgamma-/- platelets (Figure 6D). These observations suggest that additional mechanisms that underpin the decreased fibrinogen binding in thrombin-stimulated PP1cgamma-/- platelets exist and remain to be identified.
###end p 61
###begin p 62
###xml 314 317 293 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 569 572 534 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 697 700 659 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Li4">[9]</xref>
###xml 769 773 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Frame1">[31]</xref>
###xml 993 997 941 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008304-Sutherland1">[32]</xref>
The molecular basis for the relationship between the loss of PP1cgamma and decreased GSK3beta-Ser9 phosphorylation is currently unclear. PP1cgamma does not appear to directly dephosphorylate Ser9 on GSK3beta, because GSK3beta-Ser9 phosphorylation under basal conditions was not significantly increased in PP1cgamma-/- platelets. Although AKT has a major role in GSK3beta Ser9 phosphorylation, PP1cgamma does not appear to regulate GSK3beta phosphorylation via AKT, since we observed comparable level of AKT-Ser473 phosphorylation in thrombin stimulated WT and PP1cgamma-/- platelets. A potential for AKT independent regulation of GSK3beta-Ser9 phosphorylation was also noted in the previous study [9]. Since PKC, PKA or p90Rsk can also phosphorylate GSK3beta at Ser(9) [31], it is likely that PP1cgamma could affect GSK3beta Ser9 phosphorylation by regulating the activation of one or more of these Ser/Thr kinases. Alternatively, PP1cgamma may inhibit other Ser/Thr phosphatases such as PP2A [32], which may participate in dephosphorylating Ser9 on GSK3beta under conditions of thrombin stimulation thereby ensuring increased GSK3beta-Ser9 phosphorylation.
###end p 62
###begin p 63
###xml 155 158 144 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 162 163 148 149 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
In summary, our studies indicate that under conditions of low thrombin stimulation, platelet PP1cgamma is required for GSK3beta-Ser9 phosphorylation, alphaIIbbeta3 activation, soluble fibrinogen binding, platelet aggregation and stabilization of thrombus formation. The agonist specific role for PP1cgamma is intriguing and future studies will be needed to address how PP1cgamma couples specifically to signaling by PAR receptors and not to other G-protein coupled receptors.
###end p 63
###begin p 64
###xml 85 88 81 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
We thank Dr. Susannah Varmuza (University of Toronto) for providing us with PP1cgamma-/- mice.
###end p 64
###begin title 65
References
###end title 65
###begin article-title 66
Integrins: dynamic scaffolds for adhesion and signaling in platelets.
###end article-title 66
###begin article-title 67
###xml 105 108 101 104 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 112 113 105 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Mitogen-activated Protein Kinase-dependent Signaling Pathway in the Activation of Platelet Integrin alphaIIbbeta3.
###end article-title 67
###begin article-title 68
###xml 131 134 127 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 138 139 131 132 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Sequential activation of p38 and ERK pathways by cGMP-dependent protein kinase leading to activation of the platelet integrin alphaIIbbeta3.
###end article-title 68
###begin article-title 69
A platelet secretion pathway mediated by cGMP-dependent protein kinase.
###end article-title 69
###begin article-title 70
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2.
###end article-title 70
###begin article-title 71
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice.
###end article-title 71
###begin article-title 72
###xml 72 76 <span type="species:ncbi:10090">mice</span>
PKCalpha regulates platelet granule secretion and thrombus formation in mice.
###end article-title 72
###begin article-title 73
Impaired activation of platelets lacking protein kinase C-theta isoform.
###end article-title 73
###begin article-title 74
GSK3beta is a negative regulator of platelet function and thrombosis.
###end article-title 74
###begin article-title 75
Protein phosphatase 1 associates with the integrin alphaIIb subunit and regulates signaling.
###end article-title 75
###begin article-title 76
###xml 58 61 54 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 65 66 58 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Protein phosphatase 2A negatively regulates integrin alphaIIbbeta3 signaling.
###end article-title 76
###begin article-title 77
###xml 37 42 <span type="species:ncbi:9606">human</span>
Calyculin A and okadiac acid inhibit human platelet aggregation by blocking protein phosphatases types 1 and 2A.
###end article-title 77
###begin article-title 78
###xml 35 40 <span type="species:ncbi:9606">human</span>
Aggregation-dependent signaling in human platelets is sensitive to protein serine/threonine phosphatase inhibitors.
###end article-title 78
###begin article-title 79
The inhibitory effects of okadaic acid on platelet function.
###end article-title 79
###begin article-title 80
###xml 42 43 39 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Phosphorylation sites in the integrin beta3 cytoplasmic domain in intact platelets.
###end article-title 80
###begin article-title 81
Serine-threonine protein phosphatase inhibitors: development of potential therapeutic strategies.
###end article-title 81
###begin article-title 82
Protein phosphatase 1-targeted in many directions.
###end article-title 82
###begin article-title 83
Functional diversity of protein phosphatase-1, a cellular economizer and reset button.
###end article-title 83
###begin article-title 84
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Spermiogenesis is impaired in mice bearing a targeted mutation in the protein phosphatase 1cgamma gene.
###end article-title 84
###begin article-title 85
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse cremaster venules are predisposed to light/dye-induced thrombosis independent of wall shear rate, CD18, ICAM-1, or P-selectin.
###end article-title 85
###begin article-title 86
Differential role of von Willebrand factor and P-selectin on microvascular thrombosis in endotoxemia.
###end article-title 86
###begin article-title 87
###xml 132 137 <span type="species:ncbi:9606">human</span>
Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators.
###end article-title 87
###begin article-title 88
Different abilities of thrombin receptor activating peptide and thrombin to induce platelet calcium rise and full release reaction.
###end article-title 88
###begin article-title 89
###xml 49 54 <span type="species:ncbi:9606">human</span>
Differential mobilization of tyrosine kinases in human platelets stimulated with thrombin or thrombin receptor agonist peptide.
###end article-title 89
###begin article-title 90
Function of glycoprotein Ib alpha in platelet activation induced by alpha-thrombin.
###end article-title 90
###begin article-title 91
Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3.
###end article-title 91
###begin article-title 92
###xml 70 75 <span type="species:ncbi:9606">human</span>
Mechanism of activation and functional role of protein kinase Ceta in human platelets.
###end article-title 92
###begin article-title 93
###xml 112 117 <span type="species:ncbi:9606">human</span>
Protein kinase C-catalyzed phosphorylation of an inhibitory phosphoprotein of myosin phosphatase is involved in human platelet secretion.
###end article-title 93
###begin article-title 94
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B.
###end article-title 94
###begin article-title 95
###xml 44 49 <span type="species:ncbi:9606">human</span>
Regulation of glycogen synthase kinase 3 in human platelets: a possible role in platelet function?
###end article-title 95
###begin article-title 96
GSK3 takes centre stage more than 20 years after its discovery.
###end article-title 96
###begin article-title 97
Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling.
###end article-title 97
###begin p 98
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 98
###begin p 99
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from National Institutes of Health (NIH) HL081613 (K.V.V), HL079368 (R.E.R) and a Grant-In Aid 09GRNT2260224 from the American Heart Association (AHA) to K.V.V. F.C.G. is supported by the Scientist Development Grant 060180N from the AHA. S.P. was supported in part by NIH grant T-32HL072754. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
###end p 99

